|The Lion Monument at Lucerne|
During the three days of the conference, over 540 delegates from 50 countries, representing more than 270 companies and organisations from all over the globe, exchanged experiences and obtained information on the latest biocontrol products and developments in the market. Organisers commented that the vast majority of company representatives stated that they were highly satisfied with the outcome of the conference. Certainly, this was an event with a different feel as it coincided with two major industry announcements; the Bayer acquisition of AgraQuest and the intended purchase of Becker Underwood by BASF. (As we went to press, Bayer have announced yet another acquisition in the purchase of Prophyta in Germany). In the early years of the IBMA meeting, the presence of major agrochemical companies was limited. Now these recent acquisitions have brought significant changes, with some commenting that the merger of agrochemical and biological companies brings the biocontrol industry into the mainstream and the arrival of the ‘majors’ can only help in adding weight to accelerating the industry’s development.
|The KKL Centre|
In the scientific programme 41 presentations covered the latest updates in market development, regulatory affairs and novel products for plant protection. Over the two days of presentations, the eight plenary sessions covered topics such as regulatory harmonisation; industry and farming community experiences; biocontrol solutions for unusual crops, soil and seed applications, and as herbicides and nematicides; biocontrol solutions for diseases; biocontrol solutions for insects, scale and mites; and perspectives of biocontrol.
In addition, one session provided a valuable opportunity to hear of the business experiences of four companies through the eyes of their MDs or Board Members, who included Paul Koppert (Koppert B.V.), Peter Innes (Becker Underwood Ltd), Christophe Maquin (De Sangosse S.A.S.) and Peter Lüth (PROPHYTA Biologischer Pflanzenschutz GmbH).
The concluding keynote presentation on day 2 was provided by John McDougall (Phillips McDougall) but presented on their behalf by Marcus Meadows-Smith ,of the newly formed Bayer CropScience Biologics group. In the presentation entitled ‘Understanding R&D trends in agrochemical development for biocontrol companiess it was revealed that in conventional screening programmes, the number of agrochemical products that have to be processed before leading to one single successful product launch has grow from 50,000 almost 20 years ago, to 140,000 today and it takes almost 10 years between the first synthesis to the first product sale. Biological products are currently showing a 12-13 year development in comparison, but much fewer need to be screened to deliver a product which have the potential for registration. The presentation provided a summary of the expenditure and league tables of the major agrochemical companies. Other comments were provided on the rise of generics, the decline in the absolute number of actives in the market and the growth in seed biotechnology.
Perhaps one of the more popular presentations was Marcus Meadows-Smith’s own contribution, in providing insights into “Experiences of a company during an acquisition by a multinational Agchem company”. One of the key differences highlighted was size of budgets , with Marcus revealing that Bayer were investing approx €2 bn over 2011–2016 to foster future growth, a level, which is unachievable for many of the smaller industry members present.
The final presentation of the 3 days came from Vittorio Veronelli (CBC Europe) on the future of the biocontrol industry. The presentation concluded that despite all the progress, the Biocontrol industry still has a long way to go. In detail, he highlighted the need for a more specific regulatory framework, as today Regulation 1107 still has no provision for the specificity of Biocontrol products; an Expert group (IOBC) to support Member State evaluation of Biocontrol products; a much shorter “time to market” for products; a more direct contribution to research; and a better supporting program for tech transfer to growers.
Clearly there is still much to keep industry members active for many years to come. Perhaps more significant acquisitions are to follow. There was more than one utterance of ‘buy us’ references made during the scientific presentations. Certainly there was a buzz about the conference and if there was an unwritten slogan for the event it could easily have been “it is good to be green”.
Concurrent to seminars was a busy exhibition and the now established 1-to-1 networking event which provides a ‘speed dating’ opportunity for new and old attendees to establish useful contacts. Collaboration was very much in evidence throughout the event.
Next year, the 8th IBMA / ABIM meeting will be held October 21st - 23th 2013 in the new location of Basel.
|The Lakeside view always made the Lucerne Meeting a pleasant place to visit|